OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
July 02, 2010
The authors argue that the cost of generating nitrogen via an in-house gas generator is considerably lower than the cost of using fractional distillation to generate liquid nitrogen.
Duke University researchers have found a possible alternative to lyophilization.
Nanotechnology is an important area of drug and biomedical research, and advancing nano-analysis is crucial for its further development.
A history of the selection of the widely used significance level leaves much to be desired.
To continue innovating, the biopharmaceutical sector needs support from all levels.
Industry Leaders: Q&A
Varley, director of commercial operations, discusses one-stop shops and timelines.
As generic divisions become the most-wanted acquisitions of Big Pharma, India's domestic industry may be thinning out.
The authors discuss the statistical tools used in experimental planning and strategy and how to evaluate the resulting design space and its graphical representation.
The functionality and performance of three types of commercial superdisintegrants were evaluated in the application of orally disintegrating tablets.
In the Spotlight
Editors' picks of pharmaceutical science and technology innovations.
Rising labor costs in China may result in increased competition for higher value services.
Is now the time for multiparticulates to shine as a controlled-release solution?
Technical Note: The authors investigated the variables important for calcium-alginate formation as well as dissolution.
Excipient manufacturers expand their products, services, manufacturing capacity, and technology positions.
Reports of overlooked controls, dropped pallets, and misplaced documents leave a chill in the air.
From The Editor
After a spate of industrial disasters, the public seeks greater oversight of corporations-so does FDA.
More information may be released to improve public understanding of regulatory policies.
July 01, 2010
Multiparticulates in Controlled Release: Has Their Time Come?